Home / Inspections / 1018967

FDA Inspection 1018967 — Delaware Institute for Reproductive Medicine, P.A

Delaware Institute for Reproductive Medicine, P.A — FEI 3003939643

The FDA completed an inspection of Delaware Institute for Reproductive Medicine, P.A on June 8, 2017 in Newark, DE. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 8, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Newark, DE (United States)

Facility

Other inspections at this facility

  • 1293390 (NAI Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1187482 (NAI Wed Oct 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1094217 (VAI Thu Jun 20 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 925928 (NAI Wed May 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 831892 (NAI Thu May 16 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources